Laboratorios Farmaceuticos ROVI

Laboratorios Farmaceuticos ROVI Dividend

The Dividend of Laboratorios Farmaceuticos ROVI (ROVI.MC) as of Oct 31, 2026 is 0.94 EUR. In the previous year, Dividend was 1.10 EUR — a change of -15.28% (lower).

Dividend

0.94EUR

YoY

-15.28%

Dividend yield

1.49 %

Last updated:

How much dividend does Laboratorios Farmaceuticos ROVI 2026 pay?

According to the latest status from October 2026, Laboratorios Farmaceuticos ROVI paid a total of 0.94 EUR per share in dividends within the last 12 months. With the current Laboratorios Farmaceuticos ROVI price of 62.55 EUR, this corresponds to a dividend yield of 1.49 %. A dividend is paid times per year.

Laboratorios Farmaceuticos ROVI currently offers a dividend yield of about 1.49%. The payout ratio is around 34% of earnings. The dividend has grown at 15.7% per year over the past 17 years.

Historical Laboratorios Farmaceuticos ROVI Dividends

A dividend is paid times per year. Last year, the payout months were and August.

Historical Laboratorios Farmaceuticos ROVI Dividends
PaydateDividend
0.96EUR
0.94EUR
1.10EUR
1.29EUR
0.96EUR
0.38EUR
0.18EUR
0.08EUR
0.12EUR
0.18EUR
0.14EUR
0.17EUR
0.16EUR
0.14EUR
0.13EUR
0.17EUR
0.14EUR
0.09EUR
0.08EUR

The Laboratorios Farmaceuticos ROVI Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2023
1.29 EUR
Jan 1, 2024
1.10 EUR
Jan 1, 2025
0.94 EUR
Jan 1, 2026 (e)
0.96 EUR
Jan 1, 2027 (e)
1.15 EUR
Jan 1, 2028 (e)
1.38 EUR
Jan 1, 2029 (e)
1.66 EUR
Jan 1, 2030 (e)
1.99 EUR
The Laboratorios Farmaceuticos ROVI Dividend history
YEARDividendYoY
est1.99EUR+20.00%
est1.66EUR+20.00%
est1.38EUR+20.00%
est1.15EUR+20.00%
est0.96EUR+2.60%
0.94EUR-15.28%
1.10EUR-14.69%
1.29EUR+35.39%
0.96EUR+150.68%
0.38EUR+117.70%
0.18EUR+119.42%
0.08EUR-33.89%
0.12EUR-34.04%
0.18EUR+31.65%
0.14EUR-17.75%
0.17EUR+4.84%
0.16EUR+18.01%
0.14EUR+7.64%
0.13EUR-26.26%
0.17EUR+22.04%
0.14EUR+63.01%
0.09EUR+10.47%
0.08EUR—
0.00EUR—
0.00EUR—

Laboratorios Farmaceuticos ROVI dividend history and estimates

In 2025, Laboratorios Farmaceuticos ROVI paid a dividend amounting to 0.94 EUR. Dividend means that Laboratorios Farmaceuticos ROVI distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
0.38 EUR
0.00 EUR
Jan 1, 2022
0.96 EUR
0.00 EUR
Jan 1, 2023
1.29 EUR
0.00 EUR
Jan 1, 2024
1.10 EUR
0.00 EUR
Jan 1, 2025
0.94 EUR
0.00 EUR
Jan 1, 2026
0.96 EUR
0.00 EUR
Jan 1, 2027 (e)
0.00 EUR
1.15 EUR
Jan 1, 2028 (e)
0.00 EUR
1.38 EUR

Is the Laboratorios Farmaceuticos ROVI Dividend Safe?

Laboratorios Farmaceuticos ROVI has been increasing the dividend for 0 years.

Over the past 10 years, Laboratorios Farmaceuticos ROVI has increased it by an annual 18.66%.

Over a five-year period, the distribution rose by 39.80%.

Analysts expect a Dividend Increase of 1.29% for the current fiscal year.

Laboratorios Farmaceuticos ROVI dividend payout ratio

In 2025, Laboratorios Farmaceuticos ROVI had a payout ratio of 34.06%. The payout ratio indicates the percentage of the company's profits that Laboratorios Farmaceuticos ROVI distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
13.42 %
Jan 1, 2022
25.54 %
Jan 1, 2023
39.36 %
Jan 1, 2024
41.22 %
Jan 1, 2025
34.06 %
Jan 1, 2026 (e)
32.76 %
Jan 1, 2027 (e)
35.04 %
Jan 1, 2028 (e)
34.59 %

Dividend Details

Understanding Laboratorios Farmaceuticos ROVI's Dividend Distributions

Laboratorios Farmaceuticos ROVI’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Laboratorios Farmaceuticos ROVI's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Laboratorios Farmaceuticos ROVI's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Laboratorios Farmaceuticos ROVI’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Laboratorios Farmaceuticos ROVI Stock analysis

What does Laboratorios Farmaceuticos ROVI do? Laboratorios Farmaceuticos ROVI SA is a Spanish pharmaceutical company that was founded in 1946 by Salvador and Ignacio Ruiz-Salmones. The company is headquartered in Madrid and employs over 1,000 employees. ROVI manufactures a variety of pharmaceutical products and offers services in various areas. The company specializes in the development and manufacturing of specialty preparations in the fields of oncology, hematology, endocrinology, and gastroenterology. The company operates in three business areas: specialty pharmaceuticals, contrast agents, and active ingredients for the industry. The specialty pharmaceuticals business area includes medications for various applications, such as the treatment of cancer, blood disorders, endocrine disorders, gastroenterological disorders, and central nervous system disorders. The contrast agents division produces products for radiology and diagnostics. The products are used in various medical fields, from cardiology to gastroenterology. In the active ingredients for the industry business area, ROVI manufactures active ingredients for other pharmaceutical companies. ROVI specializes in the production of specialty products and relies on collaborations with other companies. The company has strategic partnerships with many companies such as GlaxoSmithKline, Pfizer, Sanofi-Aventis, and Zeltia. This also includes some research collaborations to develop and market products together. The company is also dedicated to the development of biosimilars, which allow for the offering of biologic drugs at a lower price. Biosimilars are copies of biopharmaceuticals that are usually very expensive due to the complex manufacturing process and high development costs. ROVI is also a major producer of vaccines that are distributed worldwide. ROVI has followed a solid growth trajectory in recent years. The company has been able to consistently increase its revenue and profit and is now a major player in the pharmaceutical industry. The company also operates a strong research and development department that constantly develops new products and technologies to improve patient care. In summary, Laboratorios Farmaceuticos ROVI SA is a leading pharmaceutical company specializing in the manufacturing of specialty products. With its subsidiaries in Europe and the USA, ROVI has an international presence and has made a name for itself through its expertise in the development and manufacturing of innovative pharmaceutical products. Laboratorios Farmaceuticos ROVI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laboratorios Farmaceuticos ROVI stock

Over the past 12 months, Laboratorios Farmaceuticos ROVI paid a dividend of 0.94 EUR . This corresponds to a dividend yield of about 1.49 %. For the coming 12 months, Laboratorios Farmaceuticos ROVI is expected to pay a dividend of 1.15 EUR.

The current dividend yield of Laboratorios Farmaceuticos ROVI is 1.49 %.

Laboratorios Farmaceuticos ROVI pays a dividend, distributed in the months of July.

Laboratorios Farmaceuticos ROVI paid dividends every year for the past 18 years.

For the upcoming 12 months, dividends amounting to 1.15 EUR are expected. This corresponds to a dividend yield of 1.84 %.

Laboratorios Farmaceuticos ROVI is assigned to the 'Health' sector.

In the year 2025, Laboratorios Farmaceuticos ROVI distributed 0.94 EUR as dividends.

The dividends of Laboratorios Farmaceuticos ROVI are distributed in EUR.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — Laboratorios Farmaceuticos ROVI